Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Applied Induced Pluripotent Stem Cells in Combination With Biomaterials in Bone Tissue Engineering
Rashin Mohseni
Rashin Mohseni

Assistant Professor of Applied Cellular Sciences

Pediatric Cell and Gene Therapy Research Center

Tehran University of Medical Sciences

All Documents
1. Cord Blood-Derived Platelet Gel in Wound Healing: From Biological Rationale to Clinical Application, Wound Repair and Regeneration (2026)
2. Importance of Bcg Vaccination at Birth in Pediatric Patients With Chronic Granulomatous Disease After Hematopoietic Stem Cell Transplantation in Developing Countries, Immunology Letters (2026)
3. Til Therapy in Relapsed/Refractory Neuroblastoma: A Translational Roadmap From Immunobiology to Early-Phase Trials, Critical Reviews in Oncology/Hematology (2026)
4. Autophagy and Reactive Oxygen Species in Megakaryopoiesis and Platelet Production, DNA and Cell Biology (2025)
5. Cryopreservation As an Alternative Approach for Applying Photopheresis Products to Treat Graft-Versus-Host Disease (Gvhd) Among Pediatric Patients in Developing Countries, Pediatric Transplantation (2025)
6. Long-Term Outcomes of Hematopoietic Stem Cell Transplantation in Mucopolysaccharidoses Patients Without Radiation, Clinical Transplantation (2025)
7. Natural Killer Cell-Based Therapies in Neuroblastoma, Cellular Immunology (2025)
8. Successful of Autologous Hematopoietic Stem Cell Mobilization With Plerixafor Combined With G-Csf in Pediatric Neuroblastoma Patients, a Single Center Experience, Transfusion and Apheresis Science (2025)
9. Viral-Based Gene Therapy Clinical Trials for Immune Deficiencies and Blood Disorders From 2013 Until 2023 - an Overview, Regenerative Therapy (2025)
10. Phase I Study of Safety and Efficacy of Allogeneic Natural Killer Cell Therapy in Relapsed/Refractory Neuroblastomas Post Autologous Hematopoietic Stem Cell Transplantation, Scientific Reports (2024)
11. Posterior Reversible Encephalopathy Syndrome in Pediatric Hematopoietic Stem Cell Transplantation With Beta Major Thalassemia: The Association Between the Pres Occurrence and Class of Beta Major Thalassemia, Clinical Transplantation (2024)
12. The Application of Umbilical Cord Blood-Derived Platelet Gel for Skin Ulcers Associated With Chronic Graft-Versus-Host Disease in Pediatrics: A Randomized Trial, Transplantation and Cellular Therapy (2024)
13. A Comprehensive Comparison Between Tbi Vs Non-Tbi-Based Conditioning Regimen in Pediatric Patients With Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis, Leukemia Research (2023)
14. Effect of Early Bacillus Calmette-Guerin Vaccination of Pediatric Severe Combined Immunodeficiency Patients on the Outcome of Hematopoietic Stem Cell Transplantation Using a Reduced-Intensity Conditioning Regimen, Transplantation and Cellular Therapy (2023)
15. Evaluation of Safety and Efficacy of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Pediatric Bronchiolitis Obliterans Syndrome (Bos) After Allogeneic Hematopoietic Stem Cell Transplantation (Allo-Hsct), Stem Cell Research and Therapy (2023)
16. Fanconi Anemia Phenotypic and Transplant Outcomes' Associations in Iranian Patients, Health Science Reports (2023)
17. Intra-Lesion Injection of Activated Natural Killer (Nk) Cells in Recurrent Malignant Brain Tumors, International Immunopharmacology (2023)
18. Total Body Irradiation-Free Haploidentical Peripheral Blood Stem Cell Transplantation Compared to Related and Unrelated Donor Transplantation in Pediatrics With Acute Lymphoblastic Leukemia, Pediatric Blood and Cancer (2023)
19. Adoptive Nk-Cell Transfer As a Potential Treatment Paradigm for Wilms Tumor: A Preclinical Study, Pediatric Blood and Cancer (2022)
20. An Open-Label Phase 1 Clinical Trial of the Allogeneic Side Population Adipose-Derived Mesenchymal Stem Cells in Sma Type 1 Patients, Neurological Sciences (2022)
21. Escalated Dose Donor Lymphocyte Infusion Treatment in Patients With Primary Immune Deficiencies After Hsct With Reduced-Intensity Conditioning Regimen, Hematology/ Oncology and Stem Cell Therapy (2022)
22. Fludarabine-Based Reduced Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in a Pediatric Patient With Bone Marrow Failure Syndrome Type 3, Journal of Pediatric Hematology/Oncology (2022)
23. Long-Term Follow-Up of Patients With Lps-Responsive Beige-Like Anchor Protein Deficiency After Reduced-Intensity Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation: Report of Two Cases, Hematology# Transfusion and Cell Therapy (2022)
24. Successful Allogeneic Stem Cell Transplantation With a Reduced-Intensity Conditioning in a Case of Leukocyte Adhesion Deficiency Type Iii, Hematology# Transfusion and Cell Therapy (2022)
25. Clinical Effects of Covid-19 on Hematopoietic Stem Cell Transplant Outcomes in Pediatric Patients, Experimental and Clinical Transplantation (2021)
26. Successful Allogeneic Stem Cell Transplantation With Fludarabine-Based Reduced Intensity Conditioning in Bone Marrow Failure Syndrome 4, Pediatric Transplantation (2021)
27. Overexpression of Smn2 Gene in Motoneuron-Like Cells Differentiated From Adipose-Derived Mesenchymal Stem Cells by Ponasterone A, Journal of Molecular Neuroscience (2019)
28. Emerging in Vitro 3D Tumour Models in Nanoparticle-Based Gene and Drug Therapy, Trends in Biotechnology (2018)
29. Limitations in Clinical Translation of Nanoparticle-Based Gene Therapy, Trends in Biotechnology (2017)
30. Natural Killer Cells From the Subcutaneous Adipose Tissue Underexpress the Nkp30 and Nkp44 in Obese Persons and Are Less Active Against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells, Frontiers in Immunology (2017)
31. Nk Cell-Derived Exosomes From Nk Cells Previously Exposed to Neuroblastoma Cells Augment the Antitumor Activity of Cytokine-Activated Nk Cells, Journal of Immunotherapy (2017)
32. Will Nanotechnology Bring New Hope for Gene Delivery?, Trends in Biotechnology (2017)
33. A Rapid Sonication Based Method for Preparation of Stromal Vascular Fraction and Mesenchymal Stem Cells From Fat Tissue, BioImpacts (2016)
34. Reprogramming of Endometrial Adult Stromal Cells in the Presence of a Rock Inhibitor, Thiazovivin, Could Obtain More Efficient Ipscs, Cell Biology International (2015)